Table 1.
All cases | PC death* | All cause death** | |
---|---|---|---|
All cases | 1170 | 134 (11%) | 426 (36%) |
Age at diagnosis | |||
<60 | 284 | 31 (11%) | 58 (20%) |
60-69 | 480 | 47 (10%) | 147 (31%) |
70+ | 406 | 56 (14%) | 221 (47%) |
Stage at diagnosis | |||
localized | 528 | 32 (6%) | 189 (36%) |
local extension only | 428 | 24 (6%) | 99 (23%) |
lymph node positive | 53 | 13 (25%) | 21 (40%) |
distant | 89 | 44 (49%) | 66 (74%) |
unknown | 7 | 21 (29%) | 52 (73%) |
Grade | |||
low | 725 | 38 (5%) | 215 (30%) |
high | 415 | 85 (20%) | 189 (46%) |
unknown | 30 | 11 (37%) | 21 (70%) |
Race/ethnicity | |||
African American | 349 | 40 (11%) | 132 (38%) |
Hispanic | 327 | 38 (12%) | 114 (35%) |
White | 494 | 56 (11%) | 180 (36%) |
LHR321 genotype | |||
AA | 283 | 24 (8%) | 99 (35%) |
AG | 466 | 47 (10%) | 172 (37%) |
GG | 340 | 50 (15%) | 121 (36%) |
Total | 1089 | ||
LHRH16 genotype | |||
GG | 757 | 86 (11%) | 273 (36%) |
GC | 295 | 37 (13%) | 115 (39%) |
CC | 46 | 7 (15%) | 17 (37%) |
Total | 1098 |
Number (%) of all cases who died from PC.
Number (%) of all cases who died from any cause.